SEC Form 4 · accession 0000310354-26-000074
STANDEX INTERNATIONAL CORP/DE/ · SXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A. Dunbar
Officer — President/CEO/Chairman · Director
Period of report
Aug 21, 2026
Accepted (ET)
Aug 25, 2026 · 5:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000310354
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 21, 2026 | M | 4,441 | — | A | 5,871 | D | |
| Common Stock | Aug 21, 2026 | F | 1,644 | $310.28 | D | 4,227 | D | |
| Common StockF3 | Aug 21, 2026 | M | 7,208 | — | A | 11,435 | D | |
| Common Stock | Aug 21, 2026 | F | 2,837 | $310.28 | D | 8,598 | D | |
| Common StockF4 | Aug 21, 2026 | M | 2,300 | — | A | 10,898 | D | |
| Common Stock | Aug 21, 2026 | F | 851 | $310.28 | D | 10,047 | D | |
| Common StockF4 | Aug 21, 2026 | M | 2,076 | — | A | 12,123 | D | |
| Common Stock | Aug 21, 2026 | F | 817 | $310.28 | D | 11,306 | D | |
| Common Stock | holding | — | — | — | 88,973 | I | Trustee of Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom Stock UnitsF1 | $106.10 | Aug 21, 2026 | M | 4,441 | D | Aug 23, 2026 | Aug 23, 2026 | Common Stock | 4,441 | 0 | D |
| Phantom Stock UnitsF3 | — | Aug 21, 2026 | M | 7,208 | D | Aug 23, 2026 | Aug 23, 2026 | Common Stock | 7,208 | 3,393 | D |
| Phantom Stock UnitsF5 | — | Aug 21, 2026 | D | 3,393 | D | Aug 23, 2026 | Aug 23, 2026 | Common Stock | 3,393 | 0 | D |
| Restricted Stock UnitsF4 | — | Aug 21, 2026 | M | 2,300 | D | — | — | Common Stock | 2,300 | 2,300 | D |
| Restricted Stock UnitsF4 | — | Aug 21, 2026 | M | 2,076 | D | — | — | Common Stock | 2,076 | 4,152 | D |
| Phantom Stock UnitsF6 | — | Aug 23, 2026 | A | 2,285 | A | Aug 23, 2029 | Aug 23, 2029 | Common Stock | 2,285 | 2,285 | D |
| Phantom Stock UnitsF7 | — | Aug 23, 2026 | A | 7,156 | A | Aug 23, 2029 | Aug 23, 2029 | Common Stock | 7,156 | 7,156 | D |
| Restricted Stock UnitsF8 | — | Aug 23, 2026 | A | 4,770 | A | — | — | Common Stock | 4,770 | 4,770 | D |
| Stock OptionF9 | $341.31 | Aug 23, 2026 | A | 32,600 | A | — | — | Common Stock | 32,600 | 32,600 | D |
Explanation of responses
- F1Vesting of Phantom Stock pursuant to Company's Management Stock Purchase Plan.
- F2Shares sold to pay taxes on vesting of previously issued restricted stock and/or performance share units.
- F3Vesting of Phantom Stock pursuant to the Company's 2018 Omnibus Incentive Plan. Actual achievement, which could have ranged from 0% to 250% of the award, was 68%. The transaction reported herein is the actual number of shares vesting pursuant thereto.
- F4Vesting of Restricted Stock Units pursuant to the Company's 2018 Omnibus Incentive Plan.
- F5Vesting of Phantom Stock pursuant to the Company's 2018 Omnibus Incentive Plan. Actual achievement, which could have ranged from 0% to 250% of the award, was 68%. Phantom Stock Units were granted at 100% achievement, so this transaction reflects the disposition of shares to accurately reflect the vesting.
- F6Contingent Purchase of Phantom Stock of the Company pursuant to the Management Stock Purchase Plan component of the 2018 Omnibus Incentive Plan vesting three years after the date of purchase in the form of Common Stock.
- F7Award of Performance Share Units pursuant to the 2018 Omnibus Incentive Plan of the Company. These shares cliff vest at the end of a three year performance period with the ultimate number of shares ranging from 0 to 250% of the award based on achievement against Company performance metrics of the three year period.
- F8Grant of Restricted Stock Units pursuant to the 2018 Omnibus Incentive Plan of the Company which vests one-third per year on each anniversary of the date of the award.
- F9Premium Priced Stock Option with exercise price 10% above the closing market price on the date of grant. Option vests 25% per year on each anniversary of the date of the award for four years. This option expires ten years from the date of grant.